Wednesday broker round-up
16th Jun 2021 12:50
(Sharecast News) - Pets At Home: Berenberg reiterates buy with a target price of 540p.
Read moreTuesday broker round-up
15th Jun 2021 13:39
(Sharecast News) - Page Group: Morgan Stanley downgrades to underweight with a target price of 545p.
Read moreAstraZeneca antibody fails to prevent Covid in exposed patients
15th Jun 2021 07:45
(Sharecast News) - AstraZeneca said a study of its monoclonal antibody treatment, AZD7442, did not meet the main goal of preventing symptomatic Covid-19 in people exposed to the coronavirus in the past eight days.
Read moreTuesday broker round-up
8th Jun 2021 13:54
(Sharecast News) - tinyBuild: Berenberg reiterates buy with a target price of 295p.
Read moreMonday broker round-up
7th Jun 2021 12:58
(Sharecast News) - Sainsbury's: Jefferies downgrades to hold with a target price of 280p.
Read moreNetScientific subsidiary strikes exclusive licensing deal with AstraZeneca
7th Jun 2021 09:38
(Sharecast News) - Life sciences investment company NetScientific announced on Monday that its subsidiary ProAxsis has entered into an exclusive licensing agreement with AstraZeneca.
Read moreNew data confirms AstraZeneca's confidence in Calquence
7th Jun 2021 07:38
(Sharecast News) - AstraZeneca said on Monday that final results from the head-to-head 'ELEVATE-RR' phase 3 trial of 'Calquence', or acalabrutinib, demonstrated non-inferior progression-free survival (PFS) and statistically significantly fewer events of atrial fibrillation versus ibrutinib in adults with previously-treated chronic lymphocytic leukaemia (CLL), the most common type of leukaemia in adults.
Read moreSunday newspaper round-up: Delta mutation, Foreign summer holidays, Anglo American
6th Jun 2021 12:20
(Sharecast News) - The decision to reopen on June 21 has been made "more difficult" by the Indian variant's spread to the most dominant variant in the UK, the Health Secretary has said. Matt Hancock told Sky News that the latest advice the Government has received is that the so-called Delta mutation first identified in India is 40 per cent more transmissible than the previously dominant Kent variant. - Sunday Telegraph
Read moreAstraZeneca names Dr Aradhana Sarin as CFO
4th Jun 2021 08:33
(Sharecast News) - Pharmaceutical group AstraZeneca has appointed Aradhana Sarin as chief financial officer on Friday, succeeding Marc Dunoyer upon the closing of its acquisition of Alexion Pharmaceuticals on 1 August.
Read moreEurope close: Stocks brush-off inflation readings helped by reports on US stimulus
28th May 2021 18:48
(Sharecast News) - European shares pushed further into record territory on Friday with investors apparently brushing off data in the US showing quickening inflation.
Read moreAstraZeneca lung cancer drug receives EU approval
28th May 2021 07:45
(Sharecast News) - AstraZeneca said its Tagrisso cancer drug had been approved in the European Union after positive results from a phase 3 trial.
Read moreTuesday broker round-up
25th May 2021 13:07
(Sharecast News) - Travis Perkins: Deutsche Bank resumes coverage with a recommendation to hold and a target price of 1,707p.
Read moreSilence Therapeutics receives remaining $40m from AstraZeneca partnership
25th May 2021 12:35
(Sharecast News) - Silence Therapeutics announced receipt of the remaining $40m (£28.24m) from AstraZeneca on Tuesday, due as part of AstraZeneca's $80m cash and equity investment for the siRNA collaboration announced in March 2020.
Read moreUK's CMA to probe $39bn AstraZeneca-Alexion deal
25th May 2021 08:24
(Sharecast News) - Britain's Competition and Markets Authority (CMA) said it is looking into AstraZeneca's $39bn acquisition of America's Alexion Pharmaceuticals over concerns the deal could harm competition in the UK.
Read moreAstraZeneca Covid-19 vaccine approved for emergency use in Japan
21st May 2021 07:05
(Sharecast News) - AstraZeneca's Covid-19 vaccine has been granted a special approval for emergency use in Japan for people aged 18 years and older, the company said on Friday.
Read more